- BioSig Technologies, Inc. (BSGM)
BioSig is an advanced signal processing company delivering unmatched accuracy and precision to intracardiac signal visualization, and enhancing the treatment of arrhythmias
- About BioSig - BioSig Technologies, Inc. (BSGM)
BioSig Technologies is a medical technology company focused on deciphering the body’s electrical signals, starting with heart rhythms Our technology, the PURE EP™ Platform, delivers new levels of clarity in arrhythmia identification and visualization, empowering physicians with actionable insights
- BioSig Technologies’ Common Stock to Resume Trading on the NASDAQ . . .
BioSig Technologies is a medical technology company focused on deciphering the body’s electrical signals, starting with heart rhythms By leveraging a first of its kind software, we deliver unprecedented cardiac signal clarity, ending the reliance on ‘mixed signals’ and ‘reading between the lines ’
- News Media - BioSig Technologies, Inc. (BSGM)
VANCOUVER, British Columbia LOS ANGELES-- (BUSINESS WIRE)-- BioSig Technologies, Inc (“BioSig” or the “Company”), which recently merged with Streamex Exchange Corporation (“Streamex”) (Nasdaq: BSGM), is pleased to announce the appointment of Russell Starr as Strategic Advisor to Streamex
- Learn More :: BioSig Technologies, Inc. (BSGM)
At BioSig, we're working to develop and deliver the advanced signal processing solutions that will unlock the future of bioelectronic medicine, starting with the PURE EP™ System
- The PURE EP Platform :: BioSig Technologies, Inc. (BSGM)
Frequency bandwidth comparative testing using a novel signal processing platform in a controlled bench top setting ©BioSig Technologies, Inc Rev A2 1 01 2020 [27]
- Investor Relations :: BioSig Technologies, Inc. (BSGM)
BioSig Technologies is a medical device company commercializing a proprietary technology platform designed to improve the $8 billion electrophysiology (EP) marketplace
- Profile - BioSig Technologies, Inc. (BSGM)
BioSig Technologies is a medical device company commercializing a proprietary technology platform designed to improve the $8 billion electrophysiology (EP) marketplace By 2028, the EP market is expected to reach $16 billion, with an estimated 11 2% CAGR Latest Annual Report View Annual Report Company Info Address: 12424 Wilshire Blvd Suite 745
|